PERCHERON THERAPEUTICS LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.072 AUD | +5.88% |
|
-1.37% | +22.03% |
| Feb. 28 | Percheron Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
| 2023 | Dimerix Appoints Nonexecutive Chair | MT |
Chart calendar Percheron Therapeutics Limited
7d72.Y_3rBpPyirbIgEVgTV8gNxNA08tIoh6Ig-xeKxPjlKc.IJWaP6awz9WLtCgBBDJ4ZyQnsJkg6Uz59NQ3aEyUo-VamZ5T2ae8zp3MLg~47d07fd1109732d8979455dddd580639
Upcoming events on Percheron Therapeutics Limited
Past events on Percheron Therapeutics Limited
| 2024-03-02 | Muscular Dystrophy Association Clinical and Scientific Conference - Poster No - V410 |
| 2024-03-02 | Muscular Dystrophy Association Clinical and Scientific Conference - Poster No - V409 |
| 2024-03-02 | Muscular Dystrophy Association Clinical and Scientific Conference - Poster No - M149 |
| 2024-02-28 01:20 am | Q2 2024 Earnings Release |
| 2024-01-30 05:12 pm | December 2023 Sales and Revenue Release - Activities Report |
| 2024-01-07 | JPMorgan Healthcare Conference |
| 2024-01-07 | Biotech Showcase |
| 2023-11-14 10:00 pm | Annual General Meeting |
| 2023-10-31 | AusBiotech Conference |
| 2023-10-30 06:38 pm | September 2023 Sales and Revenue Release - Activities Report |
| 2023-10-17 04:45 pm | BIO Investor Forum |
| 2023-09-08 12:00 am | ShareCafe Small Cap Hidden Gems Conference |
| 2023-08-25 04:08 am | Q4 2023 Earnings Release |
| 2023-07-27 07:37 pm | June 2023 Sales and Revenue Release - Activities Report |
| 2023-04-16 07:38 pm | March 2023 Sales and Revenue Release - Activities Report |
| 2023-02-22 12:24 am | Interim 2023 Earnings Release |
| 2023-01-24 | December 2022 Sales and Revenue Release - Activities Report |
| 2022-11-16 10:00 pm | Annual General Meeting |
| 2022-11-02 11:20 pm | Spark Plus Biotech & Medical Device Webinar |
| 2022-10-25 11:07 pm | September 2022 Sales and Revenue Release - Activities Report |
Annual results
| Fiscal Period | June | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 0,77 | 0,64 6,30 -89.89% | 1,81 1,40 29.41% | 1,96 1,80 9.15% | 3,56 |
|
EBITDA Million AUD | Released Forecast Spread | 0,00 | -7,95 -8,88 10.49% | -5,71 -11,3 49.31% | -11,3 -12,1 7.07% | -17,4 |
|
EBIT Million AUD | Released Forecast Spread | 0,00 | -8,05 -8,87 9.28% | -5,80 -11,3 48.6% | -11,4 -12,2 6.66% | -17,5 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | 0,00 | -8,06 -8,20 1.7% | 0,00 0,00 - | -11,4 -8,80 -29.32% | -17,2 |
|
Net income Million AUD | Released Forecast Spread | 0,00 | -8,06 -8,96 10.02% | 0,00 0,00 - | -11,4 -11,9 4.72% | -17,2 |
|
EPS AUD | Released Forecast Spread | 0,00 | -0,01 -0,02 6.88% | 0,00 0,00 - | -0,02 -0,02 4.39% | -0,02 |
| Announcement Date | 26/08/20 | 25/08/21 | 31/08/22 | 25/08/23 | - |
Quarterly results
| Fiscal Period | June | 2021 S2 | 2024 S1 |
|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 1,20 0,00 - | |
|
EBITDA Million AUD | Released Forecast Spread | -6,01 -6,00 -0.17% | -4,69 -8,50 44.78% |
|
EBIT Million AUD | Released Forecast Spread | -6,01 -6,00 -0.17% | -4,74 -8,50 44.23% |
|
Net income Million AUD | Released Forecast Spread | -4,74 -8,60 44.85% | |
|
EPS AUD | Released Forecast Spread | -0,01 -0,01 40% | |
| Announcement Date | 25/08/21 | 28/02/24 |
More events
Past sector events for Percheron Therapeutics Limited
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PER Stock
- Calendar Percheron Therapeutics Limited
